Saliva is superior over nasopharyngeal swab for detecting SARS-CoV2 in COVID-19 patients

Abstract Scaling up of diagnostic capacity is needed to mitigate the global pandemic of SARS-CoV2. However, there are challenges including shortage of sample collection swabs and transport medium. Saliva has been recommended as a simple, low-cost, non-invasive option. However, data from different po...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Getachew Tesfaye Beyene, Fekadu Alemu, Eyerusalem Solomon Kebede, Dawit Hailu Alemayehu, Tamirayehu Seyoum, Dessalegn Abeje Tefera, Gebeyehu Assefa, Abebech Tesfaye, Anteneh Habte, Gadissa Bedada, Birhanemeskel Tegene, Melese Yeshambaw, Liya Wassie, Adane Mihret, Alemseged Abdissa, Andargachew Mulu
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/70e28693b8ce4c8c95780f07ca2cbd5d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!